Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Bio-Rad Laboratories

US

Last updated September 17, 2026

Information

Country
US
Address
9 Holland, Irvine, CA, 92618
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3010127294
DUNS Number
—

Catalogue (1180)

Page 1 of 24
DeviceModel / ReferenceRegistriesClassStatus
Monolisa™ 26154
FDA UDI
Class IIActive
Bio-Rad Laboratories, Inc. 25271
FDA UDI
Class IIActive
Monolisa™ 26198
FDA UDI
Class IIActive
BioPlex 2200 6651360G
FDA UDI
Class IActive
Kallestad 26107
FDA UDI
Class IIActive
Liquichek 649X
FDA UDI
Class IActive
Autoimmune EIA 240DW
FDA UDI
Class IIActive
VARIANT II B-thalassemia 270-2154
FDA UDI
Class IIActive
Virotrol 00101F
FDA UDI
Class IIActive
Liquichek 267
FDA UDI
Class IActive
D-10 220-0110
FDA UDI
Class IIActive
Variant Ii Turbo 270-2415
FDA UDI
Class IIActive
Liquichek 12011343
FDA UDI
Class IIActive
Kallestad ANCA 29413
FDA UDI
Class IIActive
Liquichek 466
FDA UDI
Class IActive
VARIANT nbs Newborn Screening 250-3010
FDA UDI
Class IIActive
Liquichek 670X
FDA UDI
Class IActive
Gs 32588
FDA UDI
Class IIActive
BioPlex 2200 SW4.1_V1
FDA UDI
Class IActive
BioPlex 2200 SW4_V2
FDA UDI
Class IIActive
Lyphochek 323X
FDA UDI
Class IActive
TOX/See 194-5203
FDA UDI
Class IIActive
InteliQ 12008292
FDA UDI
Class IActive
Bio-Rad 25260
FDA UDI
Class IIActive
Bio-Rad 26181
FDA UDI
Class IIActive
BioPlex 2200 6633320
FDA UDI
Class IIActive
BioPlex 2200 SW4.1V1
FDA UDI
Class IIActive
96an 96AN-BPU-TRINITY
FDA UDI
Class IIActive
Liquichek 435
FDA UDI
Class IActive
BioPlex 2200 6631920
FDA UDI
Class IIActive
Liquichek 444X
FDA UDI
Class IActive
Gs 32591
FDA UDI
Class IIActive
BioPlex 2200 SW4.1_V2
FDA UDI
Class IIActive
BioPlex 2200 SW4.1V1
FDA UDI
Class IIActive
Liquichek 292X
FDA UDI
Class IActive
AmpliClear 00127
FDA UDI
Class IActive
Autoimmune EIA 96SA
FDA UDI
Class IIActive
Hemoglobin Variants System 250-0014
FDA UDI
Class IActive
BioPlex 2200 6633800
FDA UDI
Class IIUnknown
Virotrol 00102C
FDA UDI
Class IIActive
Liquichek 27110
FDA UDI
Class IActive
Liquichek 12003785
FDA UDI
Class IActive
Lyphochek 406
FDA UDI
Class IActive
BioPlex 2200 6632220
FDA UDI
Class IIActive
Kallestad ANCA 29401
FDA UDI
Class IIActive
InteliQ 12008310
FDA UDI
Class IIActive
TOX/See 194-5204
FDA UDI
Class IIActive
Liquichek 513
FDA UDI
Class IActive
Lyphochek 500
FDA UDI
Class IActive
BioPlex 2200 6632420
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (91)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
May 30, 2025Z-2515-2025—open, classified

Due to a risk of false positive results that could lead to unnecessary medical treatment.

Feb 15, 2024Z-1358-2024—open, classified

Due to incorrect calibrations and controls, their is a potential of incorrect reporting of lower %IS and molecular response values.

Feb 28, 2023Z-1572-2023—open, classified

APLS IgM reagent kits were packaged with the incorrect conjugate, which could lead to an increase in false-positive and false-negative results.

Feb 21, 2023Z-1377-2023—open, classified

Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positives.

Feb 21, 2023Z-1378-2023—open, classified

Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positivesBio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positivesBio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positives.There is no performance issue with the calibrator lot# 53727. They are included in the recall only because the calibrators are lot matched to the impacted reagent pack.

Oct 19, 2022Z-0342-2023—open, classified

Due to an unusual increase in the positivity rate with human IgM antibodies to cytomegalovirus (CMV) Enzyme Immunoassay (EIA).

Apr 14, 2022Z-1096-2022—open, classified

Performance concerns for the CMV IgM analyte. Analyte has demonstrated variable elevated background depending on the handling of the reagent pack.

Apr 7, 2022Z-1208-2022—open, classified

The problem is with the Bio-Rad VARIANT nbs Sickle Cell Program Resin Update CD-ROM software; Model Number: 250-3020, included in VARIANT nbs Sickle Cell Progam Reorder Pack #250-3000. This CD-ROM software included in specific lots of VARIANT nbs Sickle Cell Progam Reorder Pack causes all customized settings in the Setup/Test/Data Setup subscreen and Setup/Test/Pattern Setting subscreen to be overwritten with the default settings when the Update Kit procedure is performed.The VARIANTnbs Sickle Cell Program has been validated using the default Resin Update CDROM parameters for the intended use. However, there is a risk that the customer's custom pattern settings may be different than the default settings, resulting in a different pattern being assigned to some samples that the laboratory has validated. Following the complaints from 4 customers who experienced these issues, the firm initiated this recall.

Feb 8, 2022Z-0807-2022—open, classified

Due to current concerns related to COVID-19 vaccine interference with the RPR portion of the BioPlex 2200 Syphilis Total & RPR panel, as well as intermittent manufacturing challenges to produce RPR reagents that consistently meet stability specifications

Feb 8, 2022Z-0806-2022—open, classified

Due to current concerns related to COVID-19 vaccine interference with the RPR portion of the BioPlex 2200 Syphilis Total & RPR panel, as well as intermittent manufacturing challenges to produce RPR reagents that consistently meet stability specifications

Sep 17, 2021Z-0235-2022—open, classified

Due to two issues: 1) Customer complaints associated with greater than expected Rapid Plasma Reagin (RPR) reactivity which does not confirm with treponemal antibody test which may be due to a positive correlation between the mass COVID vaccinations and false reactive RPR results, and 2) During routine stability monitoring, an increase in mean bias above specification was observed which can cause elevated RPR reactivity potentially due to early shelf-life failure.

Sep 17, 2021Z-0236-2022—open, classified

Due to two issues: 1) Customer complaints associated with greater than expected Rapid Plasma Reagin (RPR) reactivity which does not confirm with treponemal antibody test which may be due to a positive correlation between the mass COVID vaccinations and false reactive RPR results, and 2) During routine stability monitoring, an increase in mean bias above specification was observed which can cause elevated RPR reactivity potentially due to early shelf-life failure.

Apr 21, 2020Z-2982-2020—open, classified

The increased level of RPR reactivity in the BioPlex 2200 Syphilis Total & RPR kit material number 12000650.

Nov 1, 2019Z-0082-2022—terminated

A new lot of ANA screen control and any subsequent control lots are incompatible with older lot numbers of ANA calibrators and ANA reagent packs.

Jan 10, 2019Z-1906-2019—open, classified

User-induced circumstances can contribute to the EVOLIS Microplate Processor System not handling repeat testing requests/results properly and may contribute to transmitting erroneous results to the customer's Laboratory Information System (LIS).

Jun 8, 2018Z-1743-2019—terminated

Abnormal coloration of agar plates and the growth of non-characteristic MRSA colonies.

Jun 8, 2018Z-1742-2019—terminated

Abnormal coloration of agar plates and the growth of non-characteristic MRSA colonies.

Apr 2, 2018Z-2541-2018—terminated

The connector of the power supply was capable of fitting other components provided with the system. However, the voltage output of the reader power supply is incompatible with the other component and, if incorrectly connected, could result in irreparable damage to the system.

Dec 22, 2015Z-0807-2016—terminated

The error "Washer Reagent Clean Fluid" level low alarmed, which prompted the customer to open the system drawer. When the system drawer was opened the customer noted the plate transport was still running and as a consequence the plate was pushed off the plate transporter.

Dec 15, 2015Z-0695-2016—terminated

On a rare occasion, there is a potential to assign a patient result to an incorrect sample ID when running in D10 Rack Loader configuration.

May 13, 2015Z-1840-2015—terminated

The spare component Anti-HBs Cutoff Calibrator, Catalog number 26154, is recalled because the expiration date of 2016-04-30 printed on label in error.

Apr 8, 2014Z-1537-2014—terminated

There is an issue with the buffers which impacts the quantification of the Hemoglobin F peak. Calibration and Quality control are likely to fail if the affected lots are used.

Feb 27, 2014Z-1299-2014—terminated

On a rare occasion the D-10 software might generate an extra result by duplicating the result form the previous sample and the Sample ID/Injection number from the next sample.

Nov 22, 2013Z-0965-2014—terminated

D-10 A1c Dual Program Floppy was programmed incorrectly and cartridge injections counts are not being updated correctly when switching between the D-10 Dual Short Program and Extended Program on the D-10 Hemoglobin Testing System.

Aug 20, 2013Z-0032-2014—terminated

The FSE Image Upgrade kit (part 92019C) is recalled due to issue related to the export of data from the EVOLIS analyzer to Laboratory Information Systems (LIS) when using the MONOLISA Anti-HBs EIA Quantitative Determination in EVOLIS APF version 6.0.

Apr 15, 2013Z-1330-2013—terminated

The Liquichek" ToRCH Plus IgM Control - Positive, contains detectable levels of HCV RNA which originated from the non-specific human IgM component used in the mouse monoclonal antibody conjugation process for this product.

Jul 27, 2012Z-2398-2012—terminated

Prolonged exposure of the MONOLISA Anti-HBs EIA Conjugate Diluent component to light may result in elevated Optical Densities (OD) in some samples such that a negative sample could elevate to a grey zone or low positive result.

Oct 25, 2011Z-0399-2012—terminated

It was discovered that the Variant II Turbo Link Calibrator Values card contains incorrect values for IFCC units. The numbers are missing a decimal point.

Sep 12, 2011Z-0026-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0020-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0023-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0024-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0027-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0021-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0025-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0019-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0018-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0017-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Sep 12, 2011Z-0022-2012—terminated

A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.

Jul 28, 2011Z-3159-2011—terminated

The Elution Buffer B, lot no. GA 10430, was shipped in a 2.0 L bottle instead of the standard 2.5 L bottle.

Jul 11, 2011Z-2889-2011—terminated

Reports of calibration failure and late retention time using Elution Buffer AA10434 and AA10435.

Mar 11, 2011Z-2082-2011—terminated

Bio-Rad Laboratories confirmed a downward shift in control values for EBV NA-1 analyte when using the BioPlex 2200 EBV IgG Calibrator Set Lot #46704.

Jan 20, 2011Z-1726-2011—terminated

Firm's Correction involves advising customers who have implemented a Laboratory Information System (LIS) that they need to ensure quantitative results have passed all validation criteria prior to reporting patient results. When a patient result fails a Validation Rule, the qualitative result will indicate "INVALID".

Nov 23, 2010Z-1650-2011—terminated

An upward shift in the control values can result in a control value that falls outside of the current manufacturing ranges.

Sep 7, 2010Z-0109-2011—terminated

Test Cartridges may leak and have the potential to generate error messages and biased inaccurate results.

Jul 26, 2010Z-0122-2011—terminated

Inaccurate results with high bias-- Inaccurate results may be read by the machine, creating the risk for untreated hypoglycemia at elevated altitudes.

Jul 19, 2010Z-2201-2011—terminated

The EVOLIS Assay Protocol Files Software is configured in such a way that may result in a miscalculation of quantitative test results and/or an error in reporting positive/negative sample values.

Jun 30, 2010Z-3051-2011—terminated

KALLESTAD Mouse Stomach/Kidney (MSK) test kits contained Crithidia slides instead of the MSK slides.

Jun 24, 2010Z-0612-2011—terminated

Product mislabeled-- the ANA cutoff Control and Prostiva controls were mislabeled. Use of the incorrect controls will cause run failure - patient results cannot be reported because controls will not pass..

Apr 22, 2010Z-1846-2011—terminated

The presence of parameters for Version 40400-S on the labeled VARIANT Sickle Cell Short ROM Card instead of Version 80300-S.

Apr 14, 2010Z-1984-2011—terminated

The affected resin Update CD-ROMs cause all user-defined settings in the Setup/Test/Data Setup sub screen and Set/Test/Pattern Setting sub screen to be overwritten when the Update Kit procedure is performed.

Mar 24, 2010Z-1342-2011—terminated

The firm received customer complaints associated with the Update Kit CD-ROM not being able to generate a valid calibration after being uploaded, resulting in patient results not being generated.

Mar 2, 2010Z-1648-2011—terminated

The firm received customer complaints of increased positivity rates associated with the Anti-dsDNA test kits.

Mar 2, 2010Z-1647-2011—terminated

The firm received customer complaints of increased positivity rates associated with the Anti-dsDNA test kits.

Mar 1, 2010Z-0540-2011—terminated

The ANA Screening kit generates a high percentage of false positive results, associated with a low check control reading.

Mar 1, 2010Z-1478-2011—terminated

Inaccurate results-- Consumer complaints of increased positivity rates with the ANA screening kit.

Mar 1, 2010Z-0539-2011—terminated

The ANA Screening kit generates a high percentage of false positive results, associated with a low check control reading.

Mar 1, 2010Z-1479-2011—terminated

The firm received customer complaints of increased positivity rates associated with the ANA Screening kit due to a decline in stability.

Feb 26, 2010Z-0608-2011—terminated

The value for the ANA Cutoff and ANA Positive Controls will decrease overtime resulting in an unusually elevated positivity rate for patient samples tested.

Feb 24, 2010Z-0613-2011—terminated

False positive test results caused by decrease in the OD values of ANA Cutoff Controls and ANA Positive Controls. The increased positivity rates were associated with the Meridian ANA Screening kit. False positive ANA values could result in misdiagnosis or mistreatment .

Feb 19, 2010Z-1259-2011—terminated

The results from the blood device had the occurrence of some ramping baselines on their chromatograms. The ramping baseline can affect quantitation of the blood results.

Jan 26, 2010Z-1562-2011—terminated

Pressure contained within the Elution Buffer vial may expel the rubber stopper, causing the potential for injury.

Dec 8, 2009Z-1898-2011—terminated

Wrong lot number was found on the Hemoglobin Cartridge Insert . The insert did not match the lot number to the device cartridge or the device cartridge label or on the Update Kit CD.

Dec 1, 2009Z-1932-2011—terminated

Some customers have reported the occurrence of some ramping baselines on the chromatograms. The ramping baseline can affect hemoglobin test results.

Oct 12, 2009Z-0867-2010—terminated

Product update kit CD rom will not upload. As a result, the device cannot be run.

Sep 29, 2009Z-1495-2011—terminated

Incorrect patient results are being generated from out-of-range samples tested withc ompetitive enzyme immunoassays on the PhD system with software version 2.1A.

Jul 14, 2009Z-1145-2010—terminated

The firm received customer complaints of microbial contamination in Positive Controls in its Anti-Cardiolipin IgM Test Kit Lot CL-863.

Jun 15, 2009Z-1013-2010—terminated

Calibration Failure-- due to high intercept values, the device fails calibration and users are unable to run samples.

Jan 22, 2009Z-1902-2010—terminated

Sample test results for the first run appears to be correct but all subsequent results during that run were assigned incorrect barcode and tube position.

Jan 22, 2009Z-1901-2010—terminated

Sample test results for the first run appears to be correct but all subsequent results during that run were assigned incorrect barcode and tube position.

Dec 9, 2008Z-1395-2009—terminated

The wrong barcode number and tube position number may be assigned to samples leading to discrepant sample results.

Oct 17, 2008Z-1041-2009—terminated

Sample results may be assigned to the wrong barcode number and tube position numbers, leading to discrepant sample results.

Aug 20, 2008Z-0908-2010—terminated

Elevated optical density (OD) values with the kit Negative Control.

Aug 11, 2008Z-1620-2010—terminated

The package insert provided with this kit contains a typographical error, giving incorrect directions to prepare a Working Conjugate Solution. If these directions are followed, it would result in a 1:6 dilution and invalidate the assay.

Jul 29, 2008Z-2430-2008—terminated

The Homogeneous Positive control was released with a titer of 1:256 rather than the titer value of 1:128 reported on the QC Report Label included with each test kit.

Jul 29, 2008Z-2429-2008—terminated

The Homogeneous Positive control was released with a titer of 1:256 rather than the titer value of 1:128 reported on the QC Report Label included with each test kit.

Jul 29, 2008Z-2428-2008—terminated

The Homogeneous Positive control was released with a titer of 1:256 rather than the titer value of 1:128 reported on the QC Report Label included with each test kit.

Mar 18, 2008Z-1588-2008—terminated

Some product ROM cards have an incorrect program loaded and are unable to be updated.

Mar 18, 2008Z-1589-2008—terminated

Some product ROM cards have an incorrect program loaded and are unable to be updated.

Jan 7, 2008Z-1189-2008—terminated

Incorrect result: Elevated reactivity with a kit lot 232BGG. Patient samples that are negative for antibodies to anti-HBc could be assigned a positive result.

Nov 13, 2007Z-0575-2008—terminated

Incorrect values: An error was found in the BioPlex 2200 Software, Version 2.0 that results in assignment values being utilized for the BioPlex assay Calibrator Set that may be slightly different from those printed on the Value Assignment Data Sheet. Some values may be identical between the lot assignment combinations with the ANA Screen with MDSS kit.

Nov 13, 2007Z-1157-2008—terminated

False negative results due to reagent packs exhibiting low signal.

Nov 13, 2007Z-1158-2008—terminated

False negative results due to reagent packs exhibiting low signal.

Nov 13, 2007Z-1159-2008—terminated

False negative results due to reagent packs exhibiting low signal.

Nov 13, 2007Z-1156-2008—terminated

False negative results due to reagent packs exhibiting low signal.

Sep 5, 2007Z-0065-2008—terminated

Incorrect Instruction: the package insert states to add 100L of conjugate; it should state to add 100uL.

Feb 12, 2007Z-0733-2007—terminated

The product may produce a faint line which could be interpreted as a false negative test result .

Nov 17, 2006Z-0376-2007—terminated

The Diluent in the D-10 Dual Program Calibrator reorder packs is defective, and can cause early calibration failure or elevated control and sample recovery results.

Jan 25, 2005Z-0659-05—terminated

New instructions to recommend against using samples with visibly high level of blood.

Jun 4, 2004Z-0289-06—terminated

The device was producing false negative results for cocaine tests.

Nov 6, 2003Z-0348-04—terminated

Potential drug and device interaction with piperacillin/tazobactam (Zosyn) causing positive test result for galactomannan.